Literature DB >> 18433056

Metabolic liver disease in children.

Keli Hansen1, Simon Horslen.   

Abstract

The aim of this article is to provide essential information for hepatologists, who primarily care for adults, regarding liver-based inborn errors of metabolism with particular reference to those that may be treatable with liver transplantation and to provide adequate references for more in-depth study should one of these disease states be encountered.

Entities:  

Mesh：

Year:  2008        PMID： 18433056     DOI： 10.1002/lt.21520

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


  14 in total

Review 1.  Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells.

Authors:  Behshad Pournasr; Stephen A Duncan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-17       Impact factor: 8.311

Review 2.  Therapeutic liver repopulation for phenylketonuria.

Authors:  Cary O Harding; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2010-05-22       Impact factor: 4.982

3.  Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine.

Authors:  Robert A Kaiser; Shennen A Mao; Jaime Glorioso; Bruce Amiot; Clara T Nicolas; Kari L Allen; Zeji Du; Caitlin J VanLith; Raymond D Hickey; Scott L Nyberg; Joseph B Lillegard
Journal:  J Vis Exp       Date:  2018-11-04       Impact factor: 1.355

4.  Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro.

Authors:  Vijesh Vaghjiani; Vijayaganapathy Vaithilingam; Indah Saraswati; Adnan Sali; Padma Murthi; Bill Kalionis; Bernard E Tuch; Ursula Manuelpillai
Journal:  Stem Cells Dev       Date:  2014-01-21       Impact factor: 3.272

5.  Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.

Authors:  Raymond D Hickey; Shennen A Mao; Jaime Glorioso; Faysal Elgilani; Bruce Amiot; Harvey Chen; Piero Rinaldo; Ronald Marler; Huailei Jiang; Timothy R DeGrado; Lukkana Suksanpaisan; Michael K O'Connor; Brittany L Freeman; Samar H Ibrahim; Kah Whye Peng; Cary O Harding; Chak-Sum Ho; Markus Grompe; Yasuhiro Ikeda; Joseph B Lillegard; Stephen J Russell; Scott L Nyberg
Journal:  Sci Transl Med       Date:  2016-07-27       Impact factor: 17.956

6.  Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD).

Authors:  Kristen J Skvorak; Elizabeth J Hager; Erland Arning; Teodoro Bottiglieri; Harbhajan S Paul; Stephen C Strom; Gregg E Homanics; Qin Sun; Erwin E W Jansen; Cornelis Jakobs; William J Zinnanti; K Michael Gibson
Journal:  Biochim Biophys Acta       Date:  2009-08-19

7.  Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.

Authors:  Manisha Balwani; Catherine Breen; Gregory M Enns; Patrick B Deegan; Tomas Honzík; Simon Jones; John P Kane; Vera Malinova; Reena Sharma; Eveline O Stock; Vassili Valayannopoulos; J Edmond Wraith; Jennifer Burg; Stephen Eckert; Eugene Schneider; Anthony G Quinn
Journal:  Hepatology       Date:  2013-03-28       Impact factor: 17.425

8.  Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease.

Authors:  Raymond D Hickey; Shennen A Mao; Jaime Glorioso; Joseph B Lillegard; James E Fisher; Bruce Amiot; Piero Rinaldo; Cary O Harding; Ronald Marler; Milton J Finegold; Markus Grompe; Scott L Nyberg
Journal:  Stem Cell Res       Date:  2014-05-14       Impact factor: 2.020

Review 9.  Caring for adults with pediatric liver disease.

Authors:  Michelle Rook; Philip Rosenthal
Journal:  Curr Gastroenterol Rep       Date:  2009-02

10.  Characterization of Conserved Toxicogenomic Responses in Chemically Exposed Hepatocytes across Species and Platforms.

Authors:  Nehme El-Hachem; Patrick Grossmann; Alexis Blanchet-Cohen; Alain R Bateman; Nicolas Bouchard; Jacques Archambault; Hugo J W L Aerts; Benjamin Haibe-Kains
Journal:  Environ Health Perspect       Date:  2015-07-14       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.